{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:17:07Z","timestamp":1761581827860},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T00:00:00Z","timestamp":1556755200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1038\/s41584-019-0223-9","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T11:03:17Z","timestamp":1556794997000},"page":"321-322","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Amyloid-PET: a new tool for diagnosing IBM?"],"prefix":"10.1038","volume":"15","author":[{"given":"Iago","family":"Pinal-Fernandez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L.","family":"Mammen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,2]]},"reference":[{"key":"223_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-019-0186-x","author":"SA Greenberg","year":"2019","unstructured":"Greenberg, S. A. Inclusion body myositis: clinical features and pathogenesis. Nat. Rev. Rheumatol. \n                    https:\/\/doi.org\/10.1038\/s41584-019-0186-x\n                    \n                   (2019).","journal-title":"Nat. Rev. Rheumatol."},{"key":"223_CR2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/annrheumdis-2018-214644","volume":"78","author":"JB Lilleker","year":"2019","unstructured":"Lilleker, J. B. et al. [18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis. Ann. Rheum. Dis. 78, 657\u2013662 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"223_CR3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1212\/01.wnl.0000277527.69388.fe","volume":"70","author":"N Chahin","year":"2008","unstructured":"Chahin, N. & Engel, A. G. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Neurology 70, 418\u2013424 (2008).","journal-title":"Neurology"},{"key":"223_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ana.410390122","volume":"39","author":"JN Pruitt 2nd","year":"1996","unstructured":"Pruitt, J. N. 2nd, Showalter, C. J. & Engel, A. G. Sporadic inclusion body myositis: counts of different types of abnormal fibers. Ann. Neurol. 39, 139\u2013143 (1996).","journal-title":"Ann. Neurol."},{"key":"223_CR5","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2967\/jnumed.109.069088","volume":"51","author":"DF Wong","year":"2010","unstructured":"Wong, D. F. et al. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). J. Nucl. Med. 51, 913\u2013920 (2010).","journal-title":"J. Nucl. Med."},{"key":"223_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0304-3940(95)11718-C","volume":"194","author":"FE Sherriff","year":"1995","unstructured":"Sherriff, F. E. et al. Ubiquitinated inclusions in inclusion-body myositis patients are immunoreactive for cathepsin D but not beta-amyloid. Neurosci. Lett. 194, 37\u201340 (1995).","journal-title":"Neurosci. Lett."},{"key":"223_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.114.002954","volume":"8","author":"MA Park","year":"2015","unstructured":"Park, M. A. et al. 18F-Florbetapir binds specifically to myocardial light chain and transthyretin amyloid deposits: autoradiography study. Circ. Cardiovasc. Imaging 8, e002954 (2015).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"223_CR8","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/annrheumdis-2016-210198","volume":"76","author":"I Pinal-Fernandez","year":"2017","unstructured":"Pinal-Fernandez, I. et al. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity. Ann. Rheum. Dis. 76, 681\u2013687 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"223_CR9","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/mus.24661","volume":"52","author":"G Tasca","year":"2015","unstructured":"Tasca, G. et al. Magnetic resonance imaging pattern recognition in sporadic inclusion-body myositis. Muscle Nerve 52, 956\u2013962 (2015).","journal-title":"Muscle Nerve"},{"key":"223_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/acr.22600","volume":"68","author":"TE Lloyd","year":"2016","unstructured":"Lloyd, T. E. et al. Cytosolic 5\u2032-nucleotidase 1A as a target of circulating autoantibodies in autoimmune diseases. Arthritis Care Res. 68, 66\u201371 (2016).","journal-title":"Arthritis Care Res."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41584-019-0223-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-019-0223-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-019-0223-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:19:27Z","timestamp":1684621167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-019-0223-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,2]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["223"],"URL":"https:\/\/doi.org\/10.1038\/s41584-019-0223-9","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,2]]},"assertion":[{"value":"2 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}